| Date Filed | Type | Description |
| 10/04/2023 |
4
| BREITMEYER JAMES B (CEO) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Disposed/sold 100,000 options
@ $5.76, valued at
$576k
Disposed/sold 66,890 options
@ $3.33, valued at
$222.7k
Disposed/sold 750,000 options
@ $7.05, valued at
$5.3M
Disposed/sold 637,000 options
@ $1.94, valued at
$1.2M
Disposed/sold 123,750 options
@ $1.04, valued at
$128.7k
Disposed/sold 650,000 options
@ $0.96, valued at
$624k
Granted 100,000 options
@ $0
Granted 66,890 options
@ $0
Granted 750,000 options
@ $0
Granted 637,000 options
@ $0
Granted 123,750 options
@ $0 |
|
| 07/05/2023 |
4
| BREITMEYER JAMES B (CEO) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 47,992 shares
@ $0.36, valued at
$17.3k
Paid exercise price by delivering 4,007 shares
@ $0.36, valued at
$1.4k
|
|
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2023 |
4
| BREITMEYER JAMES B (CEO) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 650,000 options
@ $0.96, valued at
$624k
Granted 65,000 options
@ $0.96, valued at
$62.4k
Granted 42,196 options
@ $0.81, valued at
$34.2k
|
|
| 01/05/2023 |
4
| BREITMEYER JAMES B (CEO) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 27,793 shares
@ $1.02, valued at
$28.3k
Paid exercise price by delivering 1,325 shares
@ $1.02, valued at
$1.4k
|
|
| 08/01/2022 |
4
| BREITMEYER JAMES B (CEO) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 185,625 shares
@ $0
Granted 18,750 shares
@ $0
Granted 123,750 options
@ $1.04, valued at
$128.7k
Granted 12,500 options
@ $1.04, valued at
$13k
|
|
| 06/23/2022 |
4
| BREITMEYER JAMES B (Director) has filed a Form 4 on OTONOMY, INC.|
Txns:
| Granted 27,500 options to buy
@ $1.95, valued at
$53.6k
|
|
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2022 |
4
| BREITMEYER JAMES B (CEO) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Bought 25,000 shares
@ $1.6832, valued at
$42.1k
|
|
| 01/24/2022 |
4
| BREITMEYER JAMES B (CEO) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 637,000 options
@ $1.94, valued at
$1.2M
Granted 165,000 options
@ $1.94, valued at
$320.1k
|
|
| 01/05/2022 |
4
| BREITMEYER JAMES B (CEO) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 128,557 shares
@ $0
Granted 6,793 shares
@ $0 |
|
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/31/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/31/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
4
| BREITMEYER JAMES B (Director) has filed a Form 4 on OTONOMY, INC.|
Txns:
| Granted 17,500 options to buy
@ $3.56, valued at
$62.3k
|
|
| 03/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2020 |
4
| BREITMEYER JAMES B (CEO) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 22,000 options
@ $4.13, valued at
$90.9k
|
|
| 12/18/2019 |
4
| BREITMEYER JAMES B (Director) has filed a Form 4 on ZOGENIX, INC.|
Txns:
| Sold 5,000 shares
@ $50, valued at
$250k
Exercised 5,000 options to buy
@ $8.99, valued at
$45k
|
|
| 11/27/2019 |
4
| BREITMEYER JAMES B (Director) has filed a Form 4 on ZOGENIX, INC.|
Txns:
| Sold 5,000 shares
@ $50, valued at
$250k
Exercised 5,000 options to buy
@ $8.99, valued at
$45k
|
|
| 09/16/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/20/2019 |
4
| BREITMEYER JAMES B (President, CEO) has filed a Form 4 on Oncternal Therapeutics, Inc.|
Txns:
| Granted 42,196 options
@ $0.81, valued at
$34.2k
|
|
| 06/13/2019 |
4
| BREITMEYER JAMES B (Director) has filed a Form 4 on OTONOMY, INC.|
Txns:
| Granted 17,500 options to buy
@ $2.35, valued at
$41.1k
|
|
| 06/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/28/2019 |
4
| BREITMEYER JAMES B (Director) has filed a Form 4 on ZOGENIX, INC.|
Txns:
| Granted 13,000 options to buy
@ $39.02, valued at
$507.3k
|
|
| 06/20/2018 |
4
| BREITMEYER JAMES B (Director) has filed a Form 4 on OTONOMY, INC.|
Txns:
| Granted 35,000 options to buy
@ $4.45, valued at
$155.8k
|
|
| 06/20/2018 |
3
| BREITMEYER JAMES B (Director) has filed a Form 3 on OTONOMY, INC. |
| 05/24/2018 |
4
| BREITMEYER JAMES B (Director) has filed a Form 4 on ZOGENIX, INC.|
Txns:
| Granted 15,000 options to buy
@ $41.68, valued at
$625.2k
|
|
|